Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives (2021)
- Authors:
- Autor USP: FERREIRA, JULIO CESAR BATISTA - ICB
- Unidade: ICB
- DOI: 10.1016/j.tips.2021.07.002
- Subjects: ANATOMIA; AMINOÁCIDOS; ATIVAÇÃO ENZIMÁTICA; GLICOSE; ERITRÓCITOS; ESTRESSE OXIDATIVO; MUTAÇÃO GENÉTICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Trends in Pharmacological Sciences
- ISSN: 1873-3735
- Volume/Número/Paginação/Ano: v. 42, n. 10, p. 829-844, 2021
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: publisher-specific-oa
-
ABNT
GARCIA, Adriana A. et al. Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives. Trends in Pharmacological Sciences, v. 42, n. 10, p. 829-844, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.tips.2021.07.002. Acesso em: 24 abr. 2024. -
APA
Garcia, A. A., Koperniku, A., Ferreira, J. C. B., & Rosen, D. M. (2021). Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives. Trends in Pharmacological Sciences, 42( 10), 829-844. doi:10.1016/j.tips.2021.07.002 -
NLM
Garcia AA, Koperniku A, Ferreira JCB, Rosen DM. Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives [Internet]. Trends in Pharmacological Sciences. 2021 ; 42( 10): 829-844.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/j.tips.2021.07.002 -
Vancouver
Garcia AA, Koperniku A, Ferreira JCB, Rosen DM. Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives [Internet]. Trends in Pharmacological Sciences. 2021 ; 42( 10): 829-844.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/j.tips.2021.07.002 - In vivo measurement of aldehyde dehydrogenase-2 activity in rat liver ethanol model using dynamic MRSI of hyperpolarized [1-13C]pyruvate
- Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Phosphorylation by Protein Kinase Cδ (PKCδ) inhibits mitochondria elimination by lysosomal-like structures following ischemia and reoxygenation-induced injury
- Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein-protein interaction inhibitor reveals a non-catalytic role for GAPDH oligomerization in cell death
- Disruption of mitochondrial quality control in peripheral arterydisease: new therapeutic opportunities
- Mitochondrial dysfunction in degenerative diseases
- Participação da isoforma proteína quinase C 'beta' II na insuficiência cardíaca
- Nitroglycerin use in myocardial infarction patients
- New therapeutics to modulate mitochondrial dynamics and mitophagy in cardiac diseases
- Mitochondrial quality control in cardiac diseases
- Targeting mitochondrial dysfunction and oxidative stress in heart failure: challenges and opportunities
Informações sobre o DOI: 10.1016/j.tips.2021.07.002 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
